-
公开(公告)号:US10214782B2
公开(公告)日:2019-02-26
申请号:US15214709
申请日:2016-07-20
Applicant: THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE , ARIZONA BOARD OF REGENTS ON BEHALF OF NORTHERN ARIZONA UNIVERSITY
Inventor: Jolene Bowers , Elizabeth Driebe , David Engelthaler , Paul Keim
Abstract: Embodiments of the invention provide a method of detecting one or more strains of Klebsiella pneumoniae. The method may include forming a plurality of mixtures for nucleic amplification. The method can include amplification of specific sequences within the K. pneumonia genome that can provide definitive information to distinguish between one or more types or strains of K. pneumonia.
-
公开(公告)号:US20190024194A1
公开(公告)日:2019-01-24
申请号:US16041711
申请日:2018-07-20
Inventor: David Engelthaler , Jolene Bowers
IPC: C12Q1/70
Abstract: A method of detecting Enterovirus D68 is provided. The method may include adding to a mixture containing the sample from the subject, (a) a first forward primer comprising SEQ ID NO: 1, (b) a second forward primer comprising SEQ ID NO: 2, (c) a third forward primer comprising SEQ ID NO: 3, (d) a first reverse primer comprising SEQ ID NO: 4, and (e) a second reverse primer comprising SEQ ID NO: 5, subjecting the mixture to conditions that allow nucleic acid amplification, and detecting the presence or absence of Enterovirus D68 by analyzing the nucleic acid amplification products. The forward primers may include a first universal tail sequence and reverse primers may include a second universal tail sequence. The nucleic acid amplification products may be sequenced using next-generation sequencing.
-
公开(公告)号:US20180173843A1
公开(公告)日:2018-06-21
申请号:US15576495
申请日:2016-05-23
Applicant: Translational Genomics Research Institute , ARIZONA BOARD OF REGENTS, ACTING FOR AND ON BEHALF OF NORTHERN ARIZONA UNIVERSITY
Inventor: Darrin Lemmer , Jolene Bowers , Erin Kelley , David Engelthaler , Elizabeth Driebe , Paul Keim
Abstract: An Amplicon Sequencing Analysis Pipeline (ASAP) system (120, 600) characterizes a genetic sample. The ASAP system (120, 600) receives assay configuration data individually associating reference sequences and genetic characteristics. The ASAP system (120, 600) processes amplicon sequencing data and the reference sequences to characterize the genetic sample based on the individual associations between the reference sequences and the genetic characteristics in the assay configuration data. The ASAP (120, 600) system transfers genetic data indicating the genetic characteristics for the genetic sample and indicating interpretation metrics for amplicon sequencing read depth and quality related to the genetic characteristics.
-
公开(公告)号:US20230130878A1
公开(公告)日:2023-04-27
申请号:US17911341
申请日:2021-03-12
Inventor: David Engelthaler , Jolene Bowers , James Schupp
IPC: C12Q1/70
Abstract: Methods, kits, and oligonucleotides used in the detection of coronavirus, for example, SARS-CoV-2, CoV-HKU1, CoV-OC43, CoV-229E, and CoV-NL63, are disclosed. A method of detecting coronavirus may include contacting a sample with at least one primer pair and probe targeting SARS-CoV-2 and at least one of: a primer pair and probe targeting CoV-HKU1, a primer pair and robe targeting CoV-OC43, a primer pair and probe targeting CoV-229E, a primer pair and probe targeting CoV-NL63, subjecting the mixture to conditions that allow nucleic acid amplification, and detecting the presence or absence of coronavirus, including SARS-CoV-2, CoV-HKU1, CoV-OC43, CoV-229E, and/or CoV-NL63, by analyzing the nucleic acid amplification products.
-
公开(公告)号:US20230128191A1
公开(公告)日:2023-04-27
申请号:US17911350
申请日:2021-03-12
Inventor: David Engelthaler , Jolene Bowers , James Schupp
IPC: C12Q1/70
Abstract: Methods, kits, and oligonucleotides used in the detection of the coronavirus strain, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are disclosed. In some aspects, the oligonucleotides are primers or probes used in the described methods or kits. The oligonucleotide consists of 42 or less nucleotides and has a nucleotide sequence that consists essentially of, or is a variant of, the nucleotide sequence of: SEQ ID NO: 1, SEQ ID NO:2, SEQ ID NO:3, SEQ ID NO:5, SEQ ID NO:6, or SEQ ID NO:7. In some embodiments, the oligonucleotide is modified with an internal spacer or a detectable label. For example, the 5′ terminus is labeled with a fluorophore and the 3′ terminus is complexed to a quencher of fluorescence of said fluorophore. In some embodiments, the nucleotide sequence of the oligonucleotide further comprises a universal tail sequence.
-
公开(公告)号:US11386977B2
公开(公告)日:2022-07-12
申请号:US15576495
申请日:2016-05-23
Applicant: Translational Genomics Research Institute , Arizona Board of Regents, Acting for and on Behalf of Northern Arizona University
Inventor: Darrin Lemmer , Jolene Bowers , Erin Kelley , David Engelthaler , Elizabeth Driebe , Paul Keim
Abstract: An Amplicon Sequencing Analysis Pipeline (ASAP) system (120, 600) characterizes a genetic sample. The ASAP system (120, 600) receives assay configuration data individually associating reference sequences and genetic characteristics. The ASAP system (120, 600) processes amplicon sequencing data and the reference sequences to characterize the genetic sample based on the individual associations between the reference sequences and the genetic characteristics in the assay configuration data. The ASAP (120, 600) system transfers genetic data indicating the genetic characteristics for the genetic sample and indicating interpretation metrics for amplicon sequencing read depth and quality related to the genetic characteristics.
-
公开(公告)号:US20220145366A1
公开(公告)日:2022-05-12
申请号:US17351172
申请日:2021-06-17
Inventor: David Engelthaler , Christopher Allender , James Schupp
Abstract: The present invention relates to oligonucleotides, methods, and kits useful for detecting an antibiotic-resistant subpopulation within a heteroresistant population of Mycobacterium tuberculosis in a sample. An amplicon of a target locus is obtained from the sample. The target locus comprises a region of interest which comprises one or more minor variants associated with the antibiotic resistance. The target locus is selected from the group consisting of: pncA, tlyA, gidB, rpsL, gyrB, embB, ahpC promoter, rplC, and combinations thereof. The amplicon is sequenced on a Next Generation Sequencing (NGS) platform. The region of interest is interrogated to detect the one or more minor variants and thus, the antibiotic-resistant subpopulation of Mycobacterium tuberculosis.
-
公开(公告)号:US11118235B2
公开(公告)日:2021-09-14
申请号:US16283232
申请日:2019-02-22
Applicant: THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE , ARIZONA BOARD OF REGENTS ON BEHALF OF NORTHERN ARIZONA UNIVERSITY
Inventor: Jolene Bowers , Elizabeth Driebe , David Engelthaler , Paul Keim
Abstract: Embodiments of the invention provide a method of detecting one or more strains of Klebsiella pneumoniae. The method may include forming a plurality of mixtures for nucleic amplification. The method can include amplification of specific sequences within the K. pneumonia genome that can provide definitive information to distinguish between one or more types or strains of K. pneumonia.
-
公开(公告)号:US20200338157A1
公开(公告)日:2020-10-29
申请号:US16921610
申请日:2020-07-06
Applicant: THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE , ARIZONA BOARD OF REGENTS ON BEHALF OF NORTHERN ARIZONA UNIVERSITY
Inventor: David Engelthaler , Elizabeth Driebe , Hongwei "Holly" Yin , Michael Valentine , Donald Chow , Jolene Bowers , Paul Keim , Bridget Barker
IPC: A61K38/13 , A61K31/7135 , A61K31/58 , A61K31/5377 , A61K31/5415 , A61K31/4196 , A61K31/496 , A61K31/495 , A61K45/06 , A61K31/138 , A61K31/277 , A61K31/353 , A61K31/404 , A61K31/4174 , A61K31/428 , A61K31/4741 , A61K31/609
Abstract: The present invention comprises methods of treating an infection using a pharmaceutical composition comprising an active ingredient selected from Table 1. In some aspects, the infection can be caused by one or more pathogens, including fungal pathogens. For example, the infection may b
-
公开(公告)号:US10213478B2
公开(公告)日:2019-02-26
申请号:US14949965
申请日:2015-11-24
Applicant: THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE , ARIZONA BOARD OF REGENTS ON BEHALF OF NORTHERN ARIZONA UNIVERSITY
Inventor: David Engelthaler , Elizabeth Driebe , Hongwei “Holly” Yin , Michael Valentine , Donald Chow , Jolene Bowers , Paul Keim
IPC: A61K31/135 , A61K31/497 , A61K31/195 , A61K38/13 , A61K31/7135 , A61K31/58 , A61K31/5377 , A61K31/5415 , A61K31/4196 , A61K31/496 , A61K31/495 , A61K45/06 , A61K31/138 , A61K31/277 , A61K31/353 , A61K31/404 , A61K31/4174 , A61K31/428 , A61K31/4741 , A61K31/609
Abstract: The present invention comprises methods of treating an infection using a pharmaceutical composition comprising an active ingredient selected from Table 1. In some aspects, the infection can be caused by one or more pathogens, including fungal pathogens. For example, the infection may be Valley Fever.
-
-
-
-
-
-
-
-
-